Notes to Financial Statements
The following section describes the organization and significant accounting policies of the Fund and provides
more detailed information about the schedules and tables that appear throughout this report. In addition, the
Notes explain how the Fund operates and the methods used in preparing and presenting this report.
1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
Janus Investment Fund (the "Trust") is registered under the Investment Company Act of 1940 (the "1940 Act")
as a no-load, open-end management investment company. The Janus Global Life Sciences Fund ("Fund") invests
primarily in equity securities. The Fund is nondiversified.
The following policies have been consistently followed by the Fund and are in conformity with accounting
principles generally accepted in the United States of America in the investment company industry.
Securities are valued at the closing price for securities traded on a principal exchange (U.S. or foreign) and on the
NASDAQ National Market. Securities traded on over-the-counter markets and listed securities for which no
sales are reported are valued at the latest bid price obtained from one or more dealers making a market for such
securities or by a pricing service approved by the Fund's Trustees. Short-term securities maturing within 60 days
are valued at amortized cost, which approximates market value. Foreign securities are converted to U.S. dollars
using exchange rates at the close of the New York Stock Exchange. When market quotations are not readily
available, securities are valued at their fair value as determined in good faith under procedures adopted by the
INVESTMENT TRANSACTIONS AND INVESTMENT INCOME
Investment transactions are accounted for as of the date purchased or sold. Dividend income is recorded on the
ex-dividend date. Certain dividends from foreign securities will be recorded as soon as the Trust is informed of
the dividend if such information is obtained subsequ